Effects of denosumab on fracture and bone mineral density by level of kidney function

Journal of Bone and Mineral Research

Volumn 26, Issue 8, 2011, Pages 1829-1835

  Jamal, Sophie A ^a   Ljunggren, Östen ^b   Stehman Breen, Catherine ^c   Cummings, Steven Ron ^d   McClung, Michael R ^e   Goemaere, Stefan ^f   Ebeling, Peter R ^g   Franek, Edward ^h   Yang, Yu Ching ^c   Egbuna, Ogo I ^c   Boonen, Steven ⁱ   Miller, Paul D ^j  

^a UNIVERSITY OF TORONTO   (Canada)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c AMGEN INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OREGON OSTEOPOROSIS CENTER   (United States)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h POLISH ACADEMY OF SCIENCES   (Poland)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

bone mineral density; denosumab; fractures; impaired kidney function

Indexed keywords

CALCIUM; CREATININE; DENOSUMAB; PLACEBO;

AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INFECTION; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CREATININE; FEMALE; FRACTURES, BONE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MIDDLE AGED; ODDS RATIO; PLACEBOS; RANK LIGAND;

EID: 79960028242     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.403     Document Type: Article

References (23)

1. Looker AC, Orwoll ES, Johnston CCJ, et al. Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res. 1997; 12: 1769-1771.
2. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 1998; 32: 992-999. (Pubitemid 28551162)
3. Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res. 1995; 10: 796-802.
4. Klawansky S, Komaroff E, Cavanaugh PFJ, et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int. 2003; 14: 570-576. (Pubitemid 36975556)
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266.
6. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009; (Suppl 113): S1-130.
7. Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH,. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int. 2007; 18: 59-68. (Pubitemid 44885496)
8. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423: 337-342. (Pubitemid 40852708)
9. Delmas PD,. Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. J Clin Densitom. 2008; 11: 325-338.
10. Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009; 361: 756-765.
11. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
12. Levey AS, Greene T, Kusek JW, Beck GJ,. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol. 2000; 11: A0828.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470. (Pubitemid 29135798)
14. Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE,. The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol. 2008; 19: 1430-1438.
15. Jamal SA, Bauer DC, Ensrud KE, et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res. 2007; 22: 503-508. (Pubitemid 47457426)
16. Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE,. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005; 20: 2105-2115. (Pubitemid 41698774)
17. Klawansky S, Komaroff E, Cavanaugh PF Jr, et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int. 2003; 14: 570-576. (Pubitemid 36975556)
18. Jamal SA, Swan VJ, Brown JP, et al. Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study. Am J Kidney Dis. 2009.
19. Ensrud KE, Lui LY, Taylor BC, et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007; 167: 133-139. (Pubitemid 46148060)
20. Nickolas TL, McMahon DJ, Shane E,. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006; 17: 3223-3232. (Pubitemid 44707784)
21. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-38. (Pubitemid 44967731)
22. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009; Aug; S1-130.
23. Miller PD,. Fragility fractures in chronic kidney disease; an opinion based approach. Cleve Clin J Med. 2009; 76: 715-723.